ARA-290

ARA-290 (Cibinetide)

WHAT IT IS

ARA-290, also known as Cibinetide, is a synthetic peptide derived from erythropoietin (EPO). It is designed to activate the innate repair receptor (IRR) to promote anti-inflammatory, neuroprotective, and tissue-repair effects without triggering the red blood cell production associated with EPO.

COMMON BENEFITS

• May help relieve neuropathic pain, especially small-fiber neuropathy
• Strong anti-inflammatory support
• Supports nerve repair and regeneration
• May help restore immune balance in autoimmune-related conditions
• Supports tissue repair in stressed or injured tissues
• May provide metabolic support for Type 2 diabetes and nerve complications
• May improve lipid and glucose metabolism

INTERACTIONS

• Use caution when combining with strong immunosuppressants or biologic anti-inflammatory medications
• May have additive effects with compounds affecting angiogenesis or tissue repair pathways
• Use caution with anticoagulants and antiplatelet medications
• Antidiabetic medications may require monitoring due to possible hypoglycemia risk

CONTRAINDICATIONS

Do not use if:
• Pregnant or breastfeeding
• Hypersensitive or allergic to this peptide
• You have active malignancy/cancer
• You have uncontrolled cardiovascular disease
• You are at high risk of thrombosis

━━━━━━━━━━━━━━━━━━
RECONSTITUTION & DOSING
━━━━━━━━━━━━━━━━━━

16MG Vial

Cycle Length
• 4, 8, or 12 week cycles
• Followed by 2, 4, or 6 week washout periods

Subcutaneous Administration

STANDARD PROTOCOL

Mix with:
• 1.5mL (150 units) BAC water

Dose:
• 18 units = 2mg
• 28 units = 3mg
• 38 units = 4mg

Frequency:
• 1x daily

MAXIMUM PROTOCOL

Mix with:
• 1mL (100 units) BAC water

Dose:
• 50 units = 8mg

Frequency:
• 1x daily
• Maximum of 4 weeks

━━━━━━━━━━━━━━━━━━
IMPORTANT NOTES
━━━━━━━━━━━━━━━━━━

• Always double check reconstitution calculations before administration
• Store according to peptide storage guidelines
• Research thoroughly before use
• Individual responses may vary